Nine Monthly Results Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
10,065.53
8,750.15
8,582.72
9,285.75
8,084.04
7,873.48
7,224.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
77.73
Total Operating income
10,065.53
8,750.15
8,582.72
9,285.75
8,084.04
7,873.48
7,302.00
Raw Material Cost
2,206.50
2,403.52
2,377.70
2,488.83
2,351.93
1,947.48
1,830.25
Purchase of Finished goods
1,221.26
1,240.37
1,069.16
879.26
572.70
848.65
804.48
(Increase) / Decrease In Stocks
-163.36
-226.04
-344.94
-13.67
-164.18
-73.54
-133.11
Employee Cost
2,285.50
2,167.19
1,987.02
1,869.74
1,806.50
1,730.54
1,561.48
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
-0.02
-0.01
0.00
0.00
1,261.95
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
2,725.27
2,474.13
2,256.71
2,204.71
1,956.12
2,187.96
755.28
Total Expenditure (Excl Depreciation)
8,275.17
8,059.16
7,345.63
7,428.86
6,523.07
6,641.09
6,080.33
Operating Profit (PBDIT) excl Other Income
1,790.36
690.99
1,237.09
1,856.89
1,560.97
1,232.39
1,221.67
Other Income
102.04
66.83
331.33
59.48
41.72
115.45
169.07
Operating Profit (PBDIT)
1,892.40
757.82
1,568.42
1,916.37
1,602.69
1,347.84
1,390.74
Interest
140.35
367.41
239.90
211.25
269.78
278.85
252.68
Exceptional Items
0.00
-335.40
138.87
0.00
44.55
0.00
167.18
Gross Profit (PBDT)
1,752.05
-63.76
1,362.40
1,526.74
1,377.46
1,068.99
1,305.25
Depreciation
360.81
430.57
434.16
355.19
332.49
290.89
244.93
Profit Before Tax
1,391.24
-494.33
928.25
1,171.55
1,044.96
778.12
1,060.32
Tax
348.48
-156.32
252.70
350.47
308.74
222.45
296.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,042.75
-338.01
675.55
821.08
736.22
555.66
763.33
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
118.77
104.99
0.00
0.00
0.00
0.00
Net Profit
1,042.75
-219.25
780.54
821.08
736.22
555.66
763.33
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.17
-23.02
-18.63
0.74
0.08
0.00
0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,042.44
-283.38
725.55
786.12
736.14
555.66
763.33
Equity Capital
28.22
28.22
28.22
28.22
28.22
28.22
28.22
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
12.33
-12.45
9.66
7.86
8.8
6.76
4.12
Operating Profit Margin (Excl OI)
17.79%
7.9%
14.41%
20.0%
19.31%
15.65%
16.73%
Gross Profit Margin
17.41%
-0.73%
15.87%
16.44%
17.04%
13.58%
17.88%
PAT Margin
10.36%
-3.86%
7.87%
8.84%
9.11%
7.06%
10.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 15.03% vs 1.95% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is 467.86% vs -139.06% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 159.10% vs -44.14% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -61.80% vs 53.15% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Glenmark Pharma With
Figures in Rs cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
10,065.53
9,199.93
865.60
9.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
10,065.53
9,199.93
865.60
9.41%
Raw Material Cost
2,206.50
1,471.08
735.42
49.99%
Purchase of Finished goods
1,221.26
1,244.57
-23.31
-1.87%
(Increase) / Decrease In Stocks
-163.36
-93.01
-70.35
-75.64%
Employee Cost
2,285.50
1,989.92
295.58
14.85%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2,725.27
2,225.77
499.50
22.44%
Total Expenditure (Excl Depreciation)
8,275.17
6,838.33
1,436.84
21.01%
Operating Profit (PBDIT) excl Other Income
1,790.36
2,361.60
-571.24
-24.19%
Other Income
102.04
287.35
-185.31
-64.49%
Operating Profit (PBDIT)
1,892.40
2,648.95
-756.55
-28.56%
Interest
140.35
238.94
-98.59
-41.26%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,752.05
2,410.01
-657.96
-27.30%
Depreciation
360.81
405.66
-44.85
-11.06%
Profit Before Tax
1,391.24
2,007.79
-616.55
-30.71%
Tax
348.48
427.80
-79.32
-18.54%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1,042.75
1,576.55
-533.80
-33.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
1,042.75
1,576.55
-533.80
-33.86%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
-0.17
-7.70
7.53
97.79%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,042.44
1,570.19
-527.75
-33.61%
Equity Capital
28.22
40.06
-11.84
-29.56%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
17.41%
26.20%
0.00
-8.79%
PAT Margin
10.36%
17.14%
0.00
-6.78%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 10,065.53 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 15.03% vs 1.95% in Dec 2023
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 1,042.44 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 467.86% vs -139.06% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,790.36 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 159.10% vs -44.14% in Dec 2023
Nine Monthly - Interest
Interest 140.35 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -61.80% vs 53.15% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.79%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
